• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过从用缺陷干扰病毒处理的感染动物的肺中获得的非中和性血凝抑制IgG的过继转移来保护小鼠免受致命流感病毒感染。

Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus.

作者信息

McLain L, Dimmock N J

机构信息

Department of Biological Sciences, University of Warwick, Coventry, U.K.

出版信息

J Gen Virol. 1989 Oct;70 ( Pt 10):2615-24. doi: 10.1099/0022-1317-70-10-2615.

DOI:10.1099/0022-1317-70-10-2615
PMID:2794973
Abstract

The lungs of C3H/HeMg mice infected with a lethal dose of the influenza virus A/WSN (H1N1) contained antibody to the viral neuraminidase glycoprotein but not to the haemagglutinin (HA). When coinoculated with a life-saving amount of defective interfering (DI) WSN, lungs were found to contain both anti-neuraminidase and haemagglutination-inhibiting (HI) antibodies which peaked at 3 and 5 days post-infection (p.i.), respectively. Mice coinoculated with WSN and beta-propiolactone-inactivated DI WSN had only anti-neuraminidase antibody in the lungs. The HI activity was unusual in that there was no detectable neutralizing activity. The HI activity has been affinity-purified by adsorption to and elution from WSN HA and consisted entirely of IgG, comprising isotypes IgG1, IgG2a and IgG2b. The antibody was specific for WSN HA, of low activity and had disappeared from the lungs by 20 days p.i. Transfer of affinity-purified HA-specific, non-neutralizing antibody to mice 24 h before infection with WSN alone protected 60% from death. We conclude that the antibody contributes significantly to the life-saving activity of DI WSN virus and that the ability to stimulate such antibody represents a novel property of this DI virus.

摘要

感染致死剂量甲型流感病毒A/WSN(H1N1)的C3H/HeMg小鼠的肺中含有针对病毒神经氨酸酶糖蛋白的抗体,但不含有针对血凝素(HA)的抗体。当与挽救生命剂量的缺陷干扰(DI)WSN共同接种时,发现肺中同时含有抗神经氨酸酶和血凝抑制(HI)抗体,它们分别在感染后(p.i.)3天和5天达到峰值。与WSN和β-丙内酯灭活的DI WSN共同接种的小鼠肺中仅含有抗神经氨酸酶抗体。HI活性不同寻常之处在于没有可检测到的中和活性。HI活性已通过吸附到WSN HA上并从其上洗脱进行亲和纯化,并且完全由IgG组成,包括IgG1、IgG2a和IgG2b同种型。该抗体对WSN HA具有特异性,活性较低,并且在感染后20天时已从肺中消失。在仅用WSN感染小鼠前24小时将亲和纯化的HA特异性、非中和性抗体转移给小鼠,可使60%的小鼠免于死亡。我们得出结论,该抗体对DI WSN病毒的挽救生命活性有显著贡献,并且刺激此类抗体的能力代表了这种DI病毒的一种新特性。

相似文献

1
Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus.通过从用缺陷干扰病毒处理的感染动物的肺中获得的非中和性血凝抑制IgG的过继转移来保护小鼠免受致命流感病毒感染。
J Gen Virol. 1989 Oct;70 ( Pt 10):2615-24. doi: 10.1099/0022-1317-70-10-2615.
2
Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication.保护小鼠免受致命性流感:有证据表明缺陷干扰病毒可调节免疫反应而非病毒增殖。
J Gen Virol. 1986 May;67 ( Pt 5):839-50. doi: 10.1099/0022-1317-67-5-839.
3
Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.H3N8马源缺陷干扰病毒对小鼠致死性人甲型H1N1流感病毒感染的异源保护作用:从缺陷干扰接种物和小鼠肺中分离的缺陷RNA序列的比较
Virology. 1998 Sep 1;248(2):241-53. doi: 10.1006/viro.1998.9267.
4
An influenza haemagglutinin-specific IgG enhances class I MHC-restricted CTL killing in vitro.流感血凝素特异性IgG在体外增强I类主要组织相容性复合体限制的细胞毒性T淋巴细胞杀伤作用。
Immunology. 1991 May;73(1):12-8.
5
Protection of three strains of mice against lethal influenza in vivo by defective interfering virus.缺陷干扰病毒对三株小鼠在体内的致死性流感的保护作用。
Virus Res. 1993 Aug;29(2):179-83. doi: 10.1016/0168-1702(93)90058-u.
6
Characterization of putative defective interfering (DI) A/WSN RNAs isolated from the lungs of mice protected from an otherwise lethal respiratory infection with influenza virus A/WSN (H1N1): a subset of the inoculum DI RNAs.从经甲型流感病毒A/WSN(H1N1)致死性呼吸道感染保护的小鼠肺中分离出的假定缺陷干扰(DI)A/WSN RNA的特征:接种物DI RNA的一个子集
Virology. 1995 Jun 20;210(1):9-19. doi: 10.1006/viro.1995.1312.
7
Protection of mice from lethal influenza by defective interfering virus: T cell responses.缺陷干扰病毒对小鼠致死性流感的保护作用:T细胞反应
J Gen Virol. 1992 Feb;73 ( Pt 2):375-81. doi: 10.1099/0022-1317-73-2-375.
8
Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus.缺陷干扰型甲型马流感病毒(H3N8)可保护小鼠免受甲型流感病毒同源和异源亚型所致的发病和死亡。
J Gen Virol. 1994 Dec;75 ( Pt 12):3485-91. doi: 10.1099/0022-1317-75-12-3485.
9
Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.通过被动转移针对不同血凝素分子的呼吸道IgA抗体对甲型流感病毒感染的交叉保护作用。
Eur J Immunol. 1991 Jun;21(6):1337-44. doi: 10.1002/eji.1830210602.
10
Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.呼吸道血凝素特异性IgA抗体在预防流感中的功能作用。
Vaccine. 1990 Oct;8(5):479-85. doi: 10.1016/0264-410x(90)90250-p.

引用本文的文献

1
Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG.基于重组核蛋白与TLR2/6激动剂BPPcysMPEG联合给药的粘膜流感疫苗制剂的保护效力
Pharmaceutics. 2023 Mar 10;15(3):912. doi: 10.3390/pharmaceutics15030912.
2
Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin.针对甲型流感病毒(H1N1pdm09)血凝素的小鼠抗体反应的多样性。
Virology. 2014 Jun;458-459:114-24. doi: 10.1016/j.virol.2014.04.011. Epub 2014 May 10.
3
Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines.
非中和性功能性抗体:HIV疫苗的一种新的“旧”范例。
Clin Vaccine Immunol. 2014 Aug;21(8):1023-36. doi: 10.1128/CVI.00230-14. Epub 2014 Jun 11.
4
Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?缺陷干扰流感病毒 RNA:重新评估其作为广谱抗病毒药物的临床潜力的时机?
J Virol. 2014 May;88(10):5217-27. doi: 10.1128/JVI.03193-13. Epub 2014 Feb 26.
5
Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.缺陷干扰流感病毒只能提供短暂的流感病毒疾病保护:适应性免疫在体内 DI 病毒介导的保护中的作用证据。
Vaccine. 2011 Sep 2;29(38):6584-91. doi: 10.1016/j.vaccine.2011.06.114. Epub 2011 Jul 14.
6
Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model.针对大流行 H1N1 2009 病毒的交叉反应性中和抗体在高度敏感的 DBA/2 小鼠流感模型中具有保护作用。
J Virol. 2010 Aug;84(15):7662-7. doi: 10.1128/JVI.02444-09. Epub 2010 May 19.
7
Pandemic influenza vaccines.大流行性流感疫苗
Curr Top Microbiol Immunol. 2009;333:291-321. doi: 10.1007/978-3-540-92165-3_15.
8
Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6.加性效应表征了参与中和初代双嗜性人类免疫缺陷病毒1型毒株89.6的抗体间的相互作用。
J Virol. 2001 Oct;75(19):9177-86. doi: 10.1128/JVI.75.19.9177-9186.2001.
9
Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody.脂质体包裹抗体增强小鼠对甲型流感病毒感染的防护作用
Immunology. 1994 Feb;81(2):280-4.
10
Insights into neutralization of animal viruses gained from study of influenza virus.从流感病毒研究中获得的关于动物病毒中和作用的见解。
Epidemiol Infect. 1991 Apr;106(2):205-20. doi: 10.1017/s0950268800048354.